The Department of Health and Human Services yesterday announced an action plan on psychiatric prescribing, including efforts to initiate deprescribing based on clinical indicators, “especially among children.” HHS said its agencies will evaluate prescription patterns for psychiatric medications, their benefits and potential harms, and “elevate the role of nonmedication treatments and scalable, evidence-based solutions to improve mental health.” The department said it is working to prevent unnecessary initiation of psychiatric medications and support tapering and discontinuation for individuals not experiencing any clinical benefit. HHS announced a series of upcoming activities on the matter regarding education and outreach, programming and policy efforts, and research-to-practice initiatives. 

Perspective
Public
May is Mental Health Awareness Month, a time to elevate a conversation that hospitals and health systems live every day. Behavioral health is inseparable from…
Headline
President Trump April 18 signed an executive order to accelerate research into psychedelic drugs for the treatment of serious mental illnesses, calling…
Headline
The White House April 2 issued a proclamation implementing additional tariffs on certain patented pharmaceutical products and ingredients. The order imposes a…
Headline
The Centers for Medicare & Medicaid Services April 2 released a final rule on policy and technical changes to Medicare Advantage, the Medicare Prescription…
Headline
The Substance Abuse and Mental Health Services Administration announced March 6 that it will award $69.1 million in grants for mental health and suicide…
Headline
The Food and Drug Administration March 5 issued a request for information seeking public comments on potential new standards for in-home opioid disposal…